Exact Mass: 400.137603
Exact Mass Matches: 400.137603
Found 87 metabolites which its exact mass value is equals to given mass value 400.137603,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
Zuclopenthixol
Zuclopenthixol is only found in individuals that have used or taken this drug. It is a thioxanthene with therapeutic actions similar to the phenothiazine antipsychotics. It is an antagonist at D1 and D2 dopamine receptors. [PubChem]Zuclopenthixol is a typical antipsychotic neuroleptic drug of the thioxanthene group. It mainly acts by antagonism of D1 and D2 dopamine receptors. Zuclopenthixol also has high affinity for alpha1-adrenergic and 5-HT2 receptors. It has weaker histamine H1 receptor blocking activity, and even lower affinity for muscarinic cholinergic and alpha2-adrenergic receptors. D002492 - Central Nervous System Depressants > D014149 - Tranquilizing Agents > D014150 - Antipsychotic Agents D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D014149 - Tranquilizing Agents N - Nervous system > N05 - Psycholeptics > N05A - Antipsychotics > N05AF - Thioxanthene derivatives D018377 - Neurotransmitter Agents > D015259 - Dopamine Agents > D018492 - Dopamine Antagonists D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants C78272 - Agent Affecting Nervous System > C29710 - Antipsychotic Agent Zuclopenthixol ((Z)-Clopenthixol) is a thioxanthene derivative which acts as a mixed dopamine D1/D2 receptor antagonist[1][2].
N-Desmethyldiltiazem
C21H24N2O4S (400.14567040000003)
N-Desmethyldiltiazem is a metabolite of diltiazem. Diltiazem is a nondihydropyridine (non-DHP) member of the class of drugs known as calcium channel blockers, used in the treatment of hypertension, angina pectoris, and some types of arrhythmia. It is also an effective preventive medication for migraine. It is a class 3 antianginal drug, and a class IV antiarrhythmic. It is a common adulterant of cocaine seized in the UK, and has been found to reduce cocaine cravings in rats, indicating it may prolong the high. (Wikipedia)
O-Desmethyldiltiazem
C21H24N2O4S (400.14567040000003)
4-(4-Butyl-2,5-dioxo-3-methyl-3-phenyl-1-pyrrolidinyl)benzenesulfonamide
C21H24N2O4S (400.14567040000003)
Repinotan
C21H24N2O4S (400.14567040000003)
3-O-beta-Glucopyranosyl plumbagic acid methyl ester
C18H24O10 (400.13694039999996)
2,2-diamino-7,8,5,6,7,8-hexahydro-3H,3H-6,6-(3-hydroxy-2-oxo-propan-1-yl-1-ylidene)-bis-pteridin-4-one|Neodrosopterin
C15H16N10O4 (400.13559360000005)
4beta-(chloromethyl)-3beta,4alpha-dihydroxy,8alpha-[(S)-3-hydroxy-2-methylpropionyloxy]-1alphaH,5alphaH,6betaH,7alphaH-guaia-10(14),11(13)-dien-6,12-olide
Regaloside D
C18H24O10 (400.13694039999996)
4-O-beta-D-glucopyranosylsinapic acid methyl ester
C18H24O10 (400.13694039999996)
Regaloside H
C18H24O10 (400.13694039999996)
Regaloside H is a natural product found in Lilium auratum, Lilium pensylvanicum, and Lilium mackliniae with data available. Regaloside H, a phenylpropanoid glycerol glucoside, is a gluconeogenesis inhibitor. Regaloside H can reduce glucose production in Hepatocytes[1].
Regaloside A
C18H24O10 (400.13694039999996)
Regaloside A is a natural product found in Lilium tenuifolium, Lilium auratum, and other organisms with data available. Regaloside A, a phenylpropanoid, shows significant DPPH radical scavenging activity of 58.0\\% at 160 ppm. Regaloside A has anti-inflammatory activity[1]. Regaloside A, a phenylpropanoid, shows significant DPPH radical scavenging activity of 58.0\% at 160 ppm. Regaloside A has anti-inflammatory activity[1].
Zuclopenthixol
D002492 - Central Nervous System Depressants > D014149 - Tranquilizing Agents > D014150 - Antipsychotic Agents D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D014149 - Tranquilizing Agents N - Nervous system > N05 - Psycholeptics > N05A - Antipsychotics > N05AF - Thioxanthene derivatives D018377 - Neurotransmitter Agents > D015259 - Dopamine Agents > D018492 - Dopamine Antagonists D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants C78272 - Agent Affecting Nervous System > C29710 - Antipsychotic Agent Zuclopenthixol ((Z)-Clopenthixol) is a thioxanthene derivative which acts as a mixed dopamine D1/D2 receptor antagonist[1][2].
(2S,3S)-2-AMINO-3-ETHOXYBUTANOICACID
C21H24N2O4S (400.14567040000003)
3,5-bis[(4-azidophenyl)methylidene]-4-oxocyclohexane-1-carboxylic acid
6-fluoro-1-(4-fluorophenyl)-7-(4-methylpiperazin-1-yl)-4-oxo-1,8-naphthyridine-3-carboxylic acid
C20H18F2N4O3 (400.1346901999999)
6-fluoro-1-(4-fluorophenyl)-7-(3-methylpiperazin-1-yl)-4-oxo-1,8-naphthyridine-3-carboxylic acid
C20H18F2N4O3 (400.1346901999999)
(2R,5S)-5-(5-Fluoro-3,4-dihydro-2,4-dioxo-1(2H)-pyrimidinyl)-1,3-oxathiolane-2-carboxylic acid (1R,2S,5R)-5-methyl-2-(1-methylethyl)cyclohexyl ester
C18H25FN2O5S (400.14681320000005)
ETHYL 3-(2-(CHLOROMETHYL)-1-METHYL-N-(PYRIDIN-2-YL)-1H-BENZO[D]IMIDAZOLE-5-CARBOXAMIDO)PROPANOATE
C20H21ClN4O3 (400.13021060000005)
Repinotan
C21H24N2O4S (400.14567040000003)
D018377 - Neurotransmitter Agents > D018490 - Serotonin Agents > D017366 - Serotonin Receptor Agonists C78272 - Agent Affecting Nervous System > C47794 - Serotonin Agonist
Sordinol
D002492 - Central Nervous System Depressants > D014149 - Tranquilizing Agents > D014150 - Antipsychotic Agents D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D014149 - Tranquilizing Agents N - Nervous system > N05 - Psycholeptics > N05A - Antipsychotics > N05AF - Thioxanthene derivatives D018377 - Neurotransmitter Agents > D015259 - Dopamine Agents > D018492 - Dopamine Antagonists D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants C78272 - Agent Affecting Nervous System > C66883 - Dopamine Antagonist
2-[[3-(4-methoxyphenyl)-7-triazolo[4,5-d]pyrimidinyl]thio]-N-(2-oxolanylmethyl)acetamide
N-(3-Phenyl-2-sulfanylpropanoyl)phenylalanylalanine
C21H24N2O4S (400.14567040000003)
Methyl(5-adenosyl)(3-hydroxy-3-carboxylatopropyl)sulfonium
C15H22N5O6S+ (400.12907320000005)
[(4S,5R,6S,8S,10R)-10-[(2,4-dioxo-1H-pyrimidin-6-yl)methyl]-5-methyl-2,11-diaza-12-azoniatricyclo[6.3.1.04,12]dodec-1(12)-en-6-yl] hydrogen sulfate
C15H22N5O6S+ (400.12907320000005)
4-[(4-Methoxyanilino)methylidene]-2-(4-methoxyphenyl)isoquinoline-1,3-dione
C24H20N2O4 (400.14230000000003)
(6R,7S,8S)-8-(hydroxymethyl)-7-[4-(2-methylphenyl)phenyl]-4-methylsulfonyl-1,4-diazabicyclo[4.2.0]octan-2-one
C21H24N2O4S (400.14567040000003)
1-[cyclopropyl(oxo)methyl]-N-(2-hydroxyethyl)-N-(phenylmethyl)-2,3-dihydroindole-5-sulfonamide
C21H24N2O4S (400.14567040000003)
1-[2,3-Bis(2-pyridinyl)-6-quinoxalinyl]-3-propylthiourea
4-[[3-[(4-methylanilino)-oxomethyl]-5,6,7,8-tetrahydro-4H-cyclohepta[b]thiophen-2-yl]amino]-4-oxobutanoic acid
C21H24N2O4S (400.14567040000003)
(6R,7R,8R)-8-(hydroxymethyl)-7-[4-(2-methylphenyl)phenyl]-4-methylsulfonyl-1,4-diazabicyclo[4.2.0]octan-2-one
C21H24N2O4S (400.14567040000003)
N-[2-[(2S,5R,6S)-5-[(3-fluorophenyl)sulfonylamino]-6-(hydroxymethyl)-2-oxanyl]ethyl]cyclopropanecarboxamide
C18H25FN2O5S (400.14681320000005)
N-[2-[(2R,5R,6R)-5-[(3-fluorophenyl)sulfonylamino]-6-(hydroxymethyl)-2-oxanyl]ethyl]cyclopropanecarboxamide
C18H25FN2O5S (400.14681320000005)
N-[2-[(2R,5R,6S)-5-[(3-fluorophenyl)sulfonylamino]-6-(hydroxymethyl)-2-oxanyl]ethyl]cyclopropanecarboxamide
C18H25FN2O5S (400.14681320000005)
N-[2-[(2S,5R,6R)-5-[(3-fluorophenyl)sulfonylamino]-6-(hydroxymethyl)-2-oxanyl]ethyl]cyclopropanecarboxamide
C18H25FN2O5S (400.14681320000005)
N-cyclobutyl-2-[(2R,5S,6R)-5-[(4-fluorophenyl)sulfonylamino]-6-(hydroxymethyl)-2-oxanyl]acetamide
C18H25FN2O5S (400.14681320000005)
N-cyclobutyl-2-[(2S,5S,6R)-5-[(4-fluorophenyl)sulfonylamino]-6-(hydroxymethyl)-2-oxanyl]acetamide
C18H25FN2O5S (400.14681320000005)
N-cyclobutyl-2-[(2S,5R,6R)-5-[(4-fluorophenyl)sulfonylamino]-6-(hydroxymethyl)-2-oxanyl]acetamide
C18H25FN2O5S (400.14681320000005)
1-[(1S,2aS,8bS)-1-(hydroxymethyl)-4-(2-methylphenyl)sulfonyl-1,2a,3,8b-tetrahydroazeto[2,3-c]quinolin-2-yl]-1-propanone
C21H24N2O4S (400.14567040000003)
(6S,7R,8R)-8-(hydroxymethyl)-7-[4-(2-methylphenyl)phenyl]-4-methylsulfonyl-1,4-diazabicyclo[4.2.0]octan-2-one
C21H24N2O4S (400.14567040000003)
(6S,7S,8R)-8-(hydroxymethyl)-7-[4-(2-methylphenyl)phenyl]-4-methylsulfonyl-1,4-diazabicyclo[4.2.0]octan-2-one
C21H24N2O4S (400.14567040000003)
N-[2-[(2R,5S,6R)-5-[(3-fluorophenyl)sulfonylamino]-6-(hydroxymethyl)-2-oxanyl]ethyl]cyclopropanecarboxamide
C18H25FN2O5S (400.14681320000005)
N-[2-[(2R,5S,6S)-5-[(3-fluorophenyl)sulfonylamino]-6-(hydroxymethyl)-2-oxanyl]ethyl]cyclopropanecarboxamide
C18H25FN2O5S (400.14681320000005)
N-[2-[(2S,5S,6R)-5-[(3-fluorophenyl)sulfonylamino]-6-(hydroxymethyl)-2-oxanyl]ethyl]cyclopropanecarboxamide
C18H25FN2O5S (400.14681320000005)
N-[2-[(2S,5S,6S)-5-[(3-fluorophenyl)sulfonylamino]-6-(hydroxymethyl)-2-oxanyl]ethyl]cyclopropanecarboxamide
C18H25FN2O5S (400.14681320000005)
N-cyclobutyl-2-[(2S,5R,6S)-5-[(4-fluorophenyl)sulfonylamino]-6-(hydroxymethyl)-2-oxanyl]acetamide
C18H25FN2O5S (400.14681320000005)
N-cyclobutyl-2-[(2R,5R,6S)-5-[(4-fluorophenyl)sulfonylamino]-6-(hydroxymethyl)-2-oxanyl]acetamide
C18H25FN2O5S (400.14681320000005)
N-cyclobutyl-2-[(2S,5S,6S)-5-[(4-fluorophenyl)sulfonylamino]-6-(hydroxymethyl)-2-oxanyl]acetamide
C18H25FN2O5S (400.14681320000005)
N-cyclobutyl-2-[(2R,5R,6R)-5-[(4-fluorophenyl)sulfonylamino]-6-(hydroxymethyl)-2-oxanyl]acetamide
C18H25FN2O5S (400.14681320000005)
N-cyclobutyl-2-[(2R,5S,6S)-5-[(4-fluorophenyl)sulfonylamino]-6-(hydroxymethyl)-2-oxanyl]acetamide
C18H25FN2O5S (400.14681320000005)
1-[(1R,2aR,8bR)-1-(hydroxymethyl)-4-(2-methylphenyl)sulfonyl-1,2a,3,8b-tetrahydroazeto[2,3-c]quinolin-2-yl]-1-propanone
C21H24N2O4S (400.14567040000003)
1-[(1S,2aR,8bR)-1-(hydroxymethyl)-4-(2-methylphenyl)sulfonyl-1,2a,3,8b-tetrahydroazeto[2,3-c]quinolin-2-yl]-1-propanone
C21H24N2O4S (400.14567040000003)
1-[(1R,2aS,8bS)-1-(hydroxymethyl)-4-(2-methylphenyl)sulfonyl-1,2a,3,8b-tetrahydroazeto[2,3-c]quinolin-2-yl]-1-propanone
C21H24N2O4S (400.14567040000003)
(6S,7S,8S)-8-(hydroxymethyl)-7-[4-(2-methylphenyl)phenyl]-4-methylsulfonyl-1,4-diazabicyclo[4.2.0]octan-2-one
C21H24N2O4S (400.14567040000003)
[(2S,3R)-6-ethylsulfonyl-2-(hydroxymethyl)-3-phenyl-1,6-diazaspiro[3.3]heptan-1-yl]-phenylmethanone
C21H24N2O4S (400.14567040000003)
[(2R,3R)-6-ethylsulfonyl-2-(hydroxymethyl)-3-phenyl-1,6-diazaspiro[3.3]heptan-1-yl]-phenylmethanone
C21H24N2O4S (400.14567040000003)
[(2S,3S)-6-ethylsulfonyl-2-(hydroxymethyl)-3-phenyl-1,6-diazaspiro[3.3]heptan-1-yl]-phenylmethanone
C21H24N2O4S (400.14567040000003)
3,4,5-Trihydroxy-6-[5-(4-hydroxy-3-methoxyphenyl)pentanoyloxy]oxane-2-carboxylic acid
C18H24O10 (400.13694039999996)
(E,5S)-4,5-dihydroxy-1-(4-hydroxyphenyl)-6-[(2R,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyhex-1-en-3-one
C18H24O10 (400.13694039999996)
Anti-5,8,13,16-tetrafluoro-4,6,12,14-tetramethoxy(2.2)metacyclophane
C20H20F4O4 (400.12976480000003)
(3s,3ar,4r,8r,11ar)-8-(acetyloxy)-3-(chloromethyl)-3-hydroxy-6,10-dimethyl-2-oxo-3ah,4h,5h,8h,9h,11ah-cyclodeca[b]furan-4-yl acetate
(2s)-3-hydroxy-2-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}propyl (2e)-3-(4-hydroxyphenyl)prop-2-enoate
C18H24O10 (400.13694039999996)
(2s,3s,4e,6s,7s)-2-(acetyloxy)-7-[(2s,3s)-3-(acetyloxy)-6-oxo-2,3-dihydropyran-2-yl]-6,7-dihydroxyhept-4-en-3-yl acetate
C18H24O10 (400.13694039999996)
(2s,4e)-2-(acetyloxy)-7-[(2s,3s)-3-(acetyloxy)-6-oxo-2,3-dihydropyran-2-yl]-6,7-dihydroxyhept-4-en-3-yl acetate
C18H24O10 (400.13694039999996)
(3s,3ar,4r,8s,11as)-8-(acetyloxy)-3-(chloromethyl)-3-hydroxy-6,10-dimethyl-2-oxo-3ah,4h,5h,8h,9h,11ah-cyclodeca[b]furan-4-yl acetate
9-(chloromethyl)-8,9-dihydroxy-3,6-dimethylidene-2-oxo-octahydroazuleno[4,5-b]furan-4-yl 3-hydroxy-2-methylpropanoate
(1e,3s,5r,6s)-5,6-bis(acetyloxy)-5-hydroxy-1-[(2s,3s)-3-hydroxy-6-oxo-2,3-dihydropyran-2-yl]hept-1-en-3-yl acetate
C18H24O10 (400.13694039999996)